Decision and Details
Execution of a commitment line agreement with Resona Bank, Limited, and expansion of the borrowing limit
To meet funding needs arising between expenditures for manufacturing the アクーゴ® product and the collection of sales proceeds from its domestic sales. By funding working capital through borrowing, the Company will allocate funds raised through share issuance and other means to growth investments, improve the flexibility and stability of financing, and strengthen the financial base supporting business expansion.
Limited impact on the consolidated earnings forecast for the fiscal year ending January 2027
| Item | Details |
|---|---|
| Matter Covered | Execution of a commitment line agreement with Resona Bank, Limited, and expansion of the borrowing limit |
| Decision Date | 30 October 2026 (date of contract execution) |
| Implementation Date | 30 October 2026 (execution of the new agreement and termination of the previous agreement; completed) |
| Period Covered | From 30 October 2026 to 30 October 2028 |
| Amount | Contract amount: ¥5 billion; previous borrowing limit: ¥1 billion |
| Quantity / scale | Borrowing limit changed from ¥1 billion to ¥5 billion (increase of ¥4 billion) |
| Impact on Business Performance | Limited impact on the consolidated earnings forecast for the fiscal year ending January 2027 |
| Reason | To meet funding needs arising between expenditures for manufacturing the アクーゴ® product and the collection of sales proceeds from its domestic sales. By funding working capital through borrowing, the Company will allocate funds raised through share issuance and other means to growth investments, improve the flexibility and stability of financing, and strengthen the financial base supporting business expansion. |
| Related previous disclosures | The previous commitment line agreement executed on 31 March 2025 (borrowing limit: ¥1 billion) |
| Future plans | Through 30 October 2028, the funds will be used for working capital related to domestic sales of the アクーゴ® product. While continuing regional expansion and expanding indications through research and development activities, the Company will develop its business into one responsible for manufacturing and selling the product. |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To meet working capital requirements arising between expenditures for manufacturing the アクーゴ® product and the collection of sales proceeds from its domestic sales. Borrowing will fund working capital, allowing funds already raised to be allocated to growth investments, while improving the flexibility and stability of financing and strengthening the financial base.